1·Median survival for patients treated with fluorouracil plus folinic acid was 23.0 months and for patients treated with gemcitabine was 23.6 months.
接受氟尿嘧啶联合亚叶酸方案治疗或是吉西他滨方案治疗患者的中位生存期分别为23.0个月及23.6个月。
2·Objective: To study the pharmacokinetics of fluorouracil acetic acid (FUAC) after oral administration.
目的：研究氟尿嘧啶乙酸口服给药后的药代动力学。
3·The results indicated that taurine could prevent small intestinal structure injury and reduction of tryptophan absorption in rats administrated with fluorouracil.
结果表明，牛磺酸可减轻氟尿嘧啶引起的大鼠小肠结构和吸收功能障碍。
4·OBJECTIVE To investigate the preparation of fluorouracil loaded chitosan microspheres.
目的制备氟尿嘧啶壳聚糖微球。
5·Conclusions Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer.
结论：卡培他滨和奥沙利铂用于先前未经治疗的食管癌和胃癌患者，效果分别与氟尿嘧啶和顺铂相同。